The ever-changing landscape of the global pharmaceutical industry is full of innovation and discovery, but it is also marred with painstaking R&D, pricing pressures, international trade obligations, changing rules and regulations, lengthy litigation, and a constantly evolving body of jurisprudence. Nathaniel Lipkus, Partner in Osler’s Intellectual Property Practice Group, is a speaker at the Roundtable Discussion: The Future of Patent Litigation in Canada. The session covers:
- Understand how drug companies manage patent litigations in a budgetconscious environment
- Learn how the Federal Court is attempting to improve the efficiency of patent proceedings
- Discuss how changes to the PM(NOC) system are set to change the landscape for drug litigants
